2026 IPO Market Turns Cold: 15 Out of 18 Newly Listed Companies Break Below IPO Price; Berkshire's Bet Bucks the Trend with 55% Gain
nashnova research
Of 18 companies that listed in the U.S. this year, 15 trade below their IPO price — most down more than half; yet Berkshire Hathaway's stake in Bending Spoons is up 55%, proving the old rule and the rare exception at the same time.
15 out of 18 below water — what happened?
*Barron's* tallied 18 U.S. IPOs in 2026: 15 now trade below their issue price, most down more than 50%.
This means → the old-school maxim "stay away from IPOs" has been validated once again.
The core driver is a valuation bubble meeting a fading theme: many deals were pitched on AI infrastructure, but once investor enthusiasm cooled, the lofty valuations collapsed.
How far have the marquee names fallen?
SpaceX (SPCX) trades around $131, below its $135 issue price — even the most watched name wasn't spared.
Cerebras Systems (CBRS) sits near $82, less than half its $185 IPO price — a drop exceeding 55%.
SK Hynix ADRs — American depositary receipts, shares that let a foreign company trade on a U.S. exchange — are around $124, below the July issue price of $149.
In plain terms = the higher the AI-driven valuation at listing, the harder the fall when the tide went out.
Who survived? What do the exceptions tell us?
Only three names held up: defense-aerospace contractor Arxis, Bill Ackman's Pershing Square, and tech-consolidation platform Bending Spoons (BSP).
This reflects a pattern: in an AI-hype washout, the survivors either carry a defensive profile (defense) or have marquee capital backing (Ackman / Berkshire).
Why did Berkshire make a rare IPO bet?
Berkshire invested $600 million in Bending Spoons' July IPO at $29 a share. The stock recently traded near $45 — a 55% gain.
In October it added another $330 million at $33 a share. Two bites, not a toe-dip — a conviction call.
Bending Spoons acquires mature tech properties such as AOL and consolidates them. This means → Berkshire wasn't buying an AI story; it was buying "acquire proven assets cheaply, then run them lean."
Put simply = Berkshire almost never touches IPOs — the last time was Snowflake in 2020. The move itself is the signal.
What tools exist for diversified IPO exposure?
The Renaissance IPO ETF adds newly listed companies each quarter, rotates them out after three years, and caps any single holding at 10%.
Its largest position is SpaceX (nearly 10%), followed by SK Hynix and Astera Labs (each above 7%). The ETF is down about 2% this year, trading near $45.
In plain terms = the ETF lets you cast a wide net across IPOs — but this year's results show that a wider net doesn't help when most of the fish are rotten.
What is the hidden risk in SK Hynix ADRs?
*Barron's* estimates SK Hynix ADRs carry a roughly 50% premium over the Korean-listed shares.
This means → on top of sector-wide chip-stock headwinds, buyers are paying an extra half in "U.S.-listing premium."
The wave of broken IPOs also creates potential bargain-hunting opportunities, but picking real value out of a pile of below-issue stocks remains the central challenge.
市场有风险，内容仅供研究参考，不构成投资建议。